| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 12,046,718 | 11,564,935 | 6,944,853 | | Cost of Revenue | 3,791,792 | 2,992,939 | 1,459,192 | | | Gross Profit | 8,254,926 | 8,571,997 | 5,485,662 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,502,921 | 4,561,803 | 3,081,275 | | Non Recurring | 6,428 | 16,532 | 69,791 | | Others | 1,286,367 | 630,783 | 475,682 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,459,210 | 3,362,880 | 1,858,914 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (33,268) |
-
|
-
| | Earnings Before Interest And Taxes | 2,311,454 | 3,267,131 | 1,731,967 | | Interest Expense | 820,491 | 865,888 | 392,422 | | Income Before Tax | 1,490,963 | 2,401,242 | 1,339,545 | | Income Tax Expense | 339,382 | 458,795 | 283,467 | | Minority Interest | (114,488) | (95,749) | (126,947) | | | | Net Income From Continuing Ops | 1,151,581 | 1,942,447 | 1,056,078 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 76,824 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,151,581 | 1,942,447 | 1,132,902 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,151,581 | $1,942,447 | $1,132,902 |
|
0.02% Nasdaq 
Income Statement
